High Court Resistant to Changing Damages Standard in Patent Fights

Generic Line
In a case with broad implications for medical patent litigation, the U.S. Supreme Court showed little enthusiasm for lowering a strict appellate standard for enhanced damages during oral arguments Feb. 23.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00